Dr. K.V.S Ram Rao is the new JMD & CEO of Granules India
He has over 29 years of experience in the field of manufacturing, R&D, business and customer service management
He has over 29 years of experience in the field of manufacturing, R&D, business and customer service management
BPZE1 is the most advanced next-generation pertussis vaccine currently in clinical development
Healthy growth in domestic and emerging markets is expected to support revenue growth in the next few quarters
ASC10 is an oral direct-acting antiviral drug candidate targeting RNA dependent RNA polymerase (RdRp) to treat SARS-CoV-2 infection
The glucometer connects to one’s smartphone and provides actionable diagnostic information
The Home Healthcare market is expected to be US $ 14.2 by 2025
The investment in Yapan Bio allows Piramal Pharma Solutions to broaden its service offerings in the fast-growing biologics CDMO space
Patient with acute Covid-19 infection treated at BGS Gleneagles Global Hospital
2022 is going to be the year of opportunities and innovations from the medical industry in India
The Indian Council of Medical Research (ICMR), intends to enter into non-exclusive agreements with companies
Subscribe To Our Newsletter & Stay Updated